MariTest
PrivateLast Round
Accelerator
Sep 11, 2023
Total Funding Raised
$600
Company Overview
MariTest is a health-tech company that develops a non-invasive, AI-powered diagnostic device for malaria detection.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MariTest Comparables
Compare MariTest with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Matibabu | 92% | |
| Fyodor Biotechnologies | 80% | |
| Disease Diagnostic Group | 77% |
MariTest Funding Rounds
Historical fundraising activity
MariTest Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Futurize | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 676% MoM.
- Oct 29, 2024
Monthly visitors increased 3233% MoM, reaching 1.3K.
MariTest Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MariTest's valuation, stock price, and market status.
Is MariTest a public or private company?
MariTest is a private company.
What is the current stock price of MariTest?
MariTest is a private company, so its shares have no public market price. Caplight tracks MariTest's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MariTest worth (valuation)?
Valuation information for MariTest is not publicly available.
Can I buy MariTest stock?
MariTest shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MariTest's last funding round?
MariTest's most recent funding round was Accelerator on September 11, 2023.
Who are the main investors in MariTest?
Key investors in MariTest include Futurize.
Will MariTest IPO soon?
No public IPO plans have been announced for MariTest.
How can I track MariTest secondary market activity?
Caplight tracks bids, offers, and trades in MariTest's shares on secondary markets.